Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Long-Term Debt Repayments (2019 - 2025)

Inventiva (IVEVF) posted Long-Term Debt Repayments of -$2.0 million for Q2 2025, down 59.95% on a QoQ basis from -$1.3 million in Q2 2024, and down 59.95% year-over-year from -$5.1 million in Q2 2024.

Analysis

Inventiva (IVEVF) Long-Term Debt Repayments (2019 - 2025) Analysis & Trends

Inventiva has reported Long-Term Debt Repayments for 5 years, with the latest figure at -$2.0 million in Q2 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 59.95% year-over-year to -$2.0 million in Q2 2025; TTM through Jun 2025 was -$3.3 million, a 154.98% decrease from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 36.56% from the prior year.
  • Long-Term Debt Repayments was -$2.0 million for Q2 2025 at Inventiva, down from -$1.3 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was -$14871.6 in Q4 2021, with the low at -$2.0 million in Q2 2025.
  • Average Long-Term Debt Repayments over 3 years is -$831347.3, with a median of -$641588.9 recorded in 2021.
  • The sharpest annual moves came in 2021 and 2025: Long-Term Debt Repayments jumped 74.01% in 2021, then tumbled 59.95% in 2025.
  • Over 3 years, Long-Term Debt Repayments stood at -$14871.6 in 2021, then slumped by 8422.92% to -$1.3 million in 2024, then tumbled by 59.95% to -$2.0 million in 2025.
  • The last three Long-Term Debt Repayments figures came in at -$2.0 million (Q2 2025), -$1.3 million (Q2 2024), and -$14871.6 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn -
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 2.00 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.23 Bn 44.23 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn -
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn -
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2.03 Mn
Jun 30, 2024 -1.27 Mn
Dec 31, 2021 -14,871.62
Mar 31, 2021 -15,681.07
Dec 31, 2020 -57,229.91
Jun 30, 2020 -15,420.44
Mar 31, 2020 -37,533.93
Dec 31, 2019 -80,802.80